JAC Advance Access published online on January 28, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh094
© 2004 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brief report
1 Department of Microbiology, Kaohsiung Medical
University, Kaohsiung;
* Corresponding author. E-mail: m725006{at}kmu.edu.tw.
Received 14 August 2003
; revised 30 November 2003
; accepted 1 December 2003
Objectives: The contribution of integrons
and efflux pumps to multidrug resistance in Stenotrophomonas maltophilia was
evaluated. Materials and methods: Ninety-three S.
maltophilia clinical isolates were studied. PCR and direct
sequencing were used to detect the presence of integrons. Real-time
PCR was performed to assess and quantify the expression of the Sme
efflux pumps of S. maltophilia. Results: Class 1 integrons were detected in
22% of clinical isolates and carried cassettes conferring
resistance mainly to aminoglycosides and trimethoprim. The small
multidrug resistance gene, smr, was found on
class 1 integrons in six isolates. Thirty-one percent of the isolates
overexpressed the smeDEF gene, as compared with
a control strain, and 59% overexpressed the smeABC gene.
Extrusion of ciprofloxacin and meropenem was specific to the SmeABC
and SmeDEF pumps, respectively. Conclusion: SmeABC and SmeDEF efflux pumps play
important roles in resistance of S. maltophilia to ciprofloxacin
and meropenem.
Keywords: real-time PCR, class 1 integrons, plasmids
Contribution of integrons, and SmeABC and SmeDEF
efflux
pumps to multidrug resistance in clinical isolates of
Stenotrophomonas maltophilia
2 Department of Food Science and
Technology, Tajen Institute of Technology, Pingtung, Taiwan
3 Department of Urology, Kaohsiung Medical
University, Kaohsiung;
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L.-L. Chang, H.-H. Lin, C.-Y. Chang, and P.-L. Lu Increased incidence of class 1 integrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia J. Antimicrob. Chemother., May 1, 2007; 59(5): 1038 - 1039. [Full Text] [PDF] |
||||
![]() |
K. Poole Efflux-mediated antimicrobial resistance J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51. [Abstract] [Full Text] [PDF] |
||||
